We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Hormel Foods
HRL
$13.4B
| $2.08M | 0.01% |
65,702
-1,585
| -2% | -$50.3K |
|
652
Axalta
AXTA
$7.93B
| $2.08M | 0.01% |
57,500
+12,200
| +27% | +$428K |
|
653
Paylocity
PCTY
$8.1B
| $2.07M | 0.01% |
12,551
+2,500
| +25% | +$380K |
|
654
Penumbra
PEN
$12.9B
| $2.07M | 0.01% |
10,658
+1,600
| +18% | +$302K |
|
655
Medpace
MEDP
$16.2B
| $2.07M | 0.01% |
6,200
+1,500
| +32% | +$570K |
|
656
First Horizon
FHN
$12.3B
| $2.07M | 0.01% |
133,119
+24,800
| +23% | +$394K |
|
657
Aaon
AAON
$7.23B
| $2.05M | 0.01% |
+19,024
| New | +$1.74M |
|
|
TMHC
658
DELISTED
Taylor Morrison
TMHC
| $2.05M | 0.01% |
29,160
+7,400
| +34% | +$474K |
|
659
Exelixis
EXEL
$12.5B
| $2.04M | 0.01% |
78,466
+17,200
| +28% | +$427K |
|
660
Webster Financial
WBS
$12.8B
| $2.02M | 0.01% |
43,393
+9,500
| +28% | +$436K |
|
|
FYBR
661
DELISTED
Frontier Communications
FYBR
| $2.02M | 0.01% |
56,900
+13,800
| +32% | +$415K |
|
662
Snap
SNAP
$8.96B
| $2M | 0.01% |
187,407
+11,830
| +7% | +$135K |
|
|
CSW
663
CSW Industrials
CSW
$5.59B
| $2M | 0.01% |
5,469
+2,100
| +62% | +$655K |
|
664
Infosys
INFY
$50.3B
| $2M | 0.01% |
90,000
| – | – |
|
665
Repligen
RGEN
$9.45B
| $2M | 0.01% |
13,433
-100
| -0.7% | -$14.3K |
|
666
Albertsons Companies
ACI
$6.02B
| $1.99M | 0.01% |
107,792
+19,500
| +22% | +$382K |
|
667
Autoliv
ALV
$8.89B
| $1.99M | 0.01% |
21,300
+5,600
| +36% | +$558K |
|
668
MasTec
MTZ
$23B
| $1.97M | 0.01% |
16,000
+2,600
| +19% | +$284K |
|
669
MKS Inc
MKSI
$20.7B
| $1.97M | 0.01% |
18,100
+5,400
| +43% | +$642K |
|
670
STAG Industrial
STAG
$7.12B
| $1.97M | 0.01% |
50,302
+12,800
| +34% | +$502K |
|
671
CBRE Group
CBRE
$44B
| $1.96M | 0.01% |
15,726
+917
| +6% | +$100K |
|
672
Cirrus Logic
CRUS
$6.08B
| $1.95M | 0.01% |
15,695
+2,700
| +21% | +$358K |
|
673
Badger Meter
BMI
$3.78B
| $1.95M | 0.01% |
8,909
+1,520
| +21% | +$305K |
|
|
BERY
674
DELISTED
Berry Global Group, Inc.
BERY
| $1.94M | 0.01% |
31,102
+3,703
| +14% | +$220K |
|
675
Middleby
MIDD
$5.29B
| $1.93M | 0.01% |
13,900
+1,700
| +14% | +$228K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.